$ORGS
Orgenesis Inc. Stock $orgs

$orgs Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000149315223008574 Filed on March 22, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$7.044M	$13.62M	$36.03M
YoY Change	-2.33%	97.68%	1.47%
Cost Of Revenue	$2.722M	$6.134M	$27.07M
YoY Change	281.23%		-26.14%
Gross Profit	$4.322M	$7.490M	$8.959M
YoY Change	-33.49%		-884.5%
Gross Profit Margin	61.36%	54.98%	24.87%
Selling, General & Admin	$4.039M	$6.831M	$15.59M
YoY Change	20.21%	153.56%	10.63%
% of Gross Profit	93.45%	91.2%	174.0%
Research & Development	$3.281M	$2.064M	$9.169M
YoY Change	-50.39%	-80.52%	-74.77%
% of Gross Profit	75.91%	27.56%	102.34%
Depreciation & Amortization	$578.0K	$225.0K	$1.067M
YoY Change	21.94%	-53.13%	-42.76%
% of Gross Profit	13.37%	3.0%	11.91%
Operating Expenses	$7.320M	$7.056M	$15.59M
YoY Change	-29.94%	-48.86%	-70.19%
Operating Profit	-$3.205M	$434.0K	-$8.602M
YoY Change	-0.96%		-48.8%
Interest Expense	-$645.0K	-$588.0K	-$3.479M
YoY Change	-14.46%	19.27%	94.47%
% of Operating Profit		-135.48%
Other Income/Expense, Net	-$644.0K	$167.0K	-$1.971M
YoY Change	10633.33%	-93.11%	-178.75%
Pretax Income	-$4.132M	-$1.100M	-$11.96M
YoY Change	3.4%	-77.89%	-33.37%
Income Tax	$129.0K	$172.0K	$209.0K
% Of Pretax Income
Net Earnings	-$4.189M	-$4.097M	-$14.89M
YoY Change	4.49%	-18.32%	-17.53%
Net Earnings / Revenue	-59.47%	-30.07%	-41.33%
Basic Earnings Per Share	$0.16		$0.59
Diluted Earnings Per Share	-$0.16	-$0.16	-$0.59
COMMON SHARES
Basic Shares Outstanding	27.49M shares	25.55M shares	25.10M shares
Diluted Shares Outstanding	26.48M shares		25.10M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.674M	$5.311M	$5.311M
YoY Change	138.11%	-2.96%	-2.96%
Cash & Equivalents	$2.674M	$5.311M	$5.311M
Short-Term Investments
Other Short-Term Assets	$6.184M	$2.016M	$2.016M
YoY Change	220.75%	19.36%	19.36%
Inventory	$128.0K	$120.0K	$120.0K
Prepaid Expenses
Receivables	$37.74M	$36.18M	$36.18M
Other Receivables	$2.725M	$2.688M	$2.688M
Total Short-Term Assets	$49.45M	$46.32M	$46.32M
YoY Change	105.96%	79.82%	79.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$21.81M	$22.83M	$25.14M
YoY Change	81.88%	122.32%	122.74%
Goodwill	$8.069M	$8.187M
YoY Change		-2.57%
Intangibles	$9.430M	$9.694M
YoY Change		-17.99%
Long-Term Investments	$136.0K	$135.0K	$135.0K
YoY Change	-91.36%	-11.18%	-11.18%
Other Assets	$1.044M	$1.022M	$1.456M
YoY Change	-4.74%	26.96%	24.66%
Total Long-Term Assets	$43.82M	$44.61M	$44.61M
YoY Change	26.9%	30.89%	30.89%
TOTAL ASSETS
Total Short-Term Assets	$49.45M	$46.32M	$46.32M
Total Long-Term Assets	$43.82M	$44.61M	$44.61M
Total Assets	$93.27M	$90.93M	$90.93M
YoY Change	59.33%	51.95%	51.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.387M	$4.429M	$4.429M
YoY Change	-36.72%	-15.44%	-15.44%
Accrued Expenses	$2.510M	$2.578M	$4.980M
YoY Change	-29.65%	-10.27%	73.34%
Deferred Revenue	$106.0K	$70.00K
YoY Change	51.43%	18.64%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.376M	$4.564M	$4.564M
YoY Change	-29.6%	-22.68%	-22.68%
Total Short-Term Liabilities	$13.94M	$15.91M	$15.91M
YoY Change	-8.62%	3.55%	3.55%
LONG-TERM LIABILITIES
Long-Term Debt	$17.37M	$13.44M	$13.44M
YoY Change	129.14%	174.53%	174.53%
Other Long-Term Liabilities	$266.0K	$271.0K	$2.306M
YoY Change	-68.63%	-5.9%	142.74%
Total Long-Term Liabilities	$20.02M	$15.74M	$15.74M
YoY Change	137.55%	169.36%	169.36%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.94M	$15.91M	$15.91M
Total Long-Term Liabilities	$20.02M	$15.74M	$15.74M
Total Liabilities	$33.96M	$31.65M	$63.37M
YoY Change	42.47%	49.24%	196.76%
SHAREHOLDERS EQUITY
Retained Earnings	-$125.0M	-$121.0M
YoY Change		13.75%
Common Stock	$154.7M	$150.4M
YoY Change		3.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.266M	$1.266M
YoY Change		0.0%
Treasury Stock Shares		286.6K shares
Shareholders Equity	$27.67M	$27.56M	$27.56M
YoY Change
Total Liabilities & Shareholders Equity	$93.27M	$90.93M	$90.93M
YoY Change	59.33%	51.95%	51.95%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$4.189M	-$4.097M	-$14.89M
YoY Change	4.49%	-18.32%	-17.53%
Depreciation, Depletion And Amortization	$578.0K	$225.0K	$1.067M
YoY Change	21.94%	-53.13%	-42.76%
Cash From Operating Activities	-$7.200M	-$10.76M	-$24.90M
YoY Change	157.88%	336.73%	-7.32%
INVESTING ACTIVITIES
Capital Expenditures	$1.285M	$5.445M	$12.42M
YoY Change	-242.46%	-220.84%	-257.84%
Acquisitions
YoY Change
Other Investing Activities	-$22.00K	-$1.230M	-$1.717M
YoY Change	-96.91%	-0.32%	-62.0%
Cash From Investing Activities	-$1.307M	-$6.675M	-$14.13M
YoY Change	-18.97%	16.29%	14.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$5.910M	19.48M	$39.58M
YoY Change	590900.0%	-1879.27%	-37437.74%
NET CHANGE
Cash From Operating Activities	-$7.200M	-10.76M	-$24.90M
Cash From Investing Activities	-$1.307M	-6.675M	-$14.13M
Cash From Financing Activities	$5.910M	19.48M	$39.58M
Net Change In Cash	-$2.597M	2.047M	$545.0K
YoY Change	-41.03%	-122.01%	-101.38%
FREE CASH FLOW
Cash From Operating Activities	-$7.200M	-$10.76M	-$24.90M
Capital Expenditures	$1.285M	$5.445M	$12.42M
Free Cash Flow	-$8.485M	-$16.21M	-$37.32M
YoY Change	348.94%	-893.63%	96.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001460602
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent		usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent		usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet		usd
CY2021Q4	ORGS	Advance Payments On Account Of Grant Non Current AdvancePaymentsOnAccountOfGrantNonCurrent		usd
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount		usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability		usd
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes		usd
CY2022	ORGS	Payments For Investment In Convertible Loan To Related Party PaymentsForInvestmentInConvertibleLoanToRelatedParty		usd
CY2021	ORGS	Proceeds From Repayment Of Convertible Loan To Related Party Partners ProceedsFromRepaymentOfConvertibleLoanToRelatedPartyPartners		usd
CY2022	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable		usd
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2022	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates		usd
CY2021	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
CY2021	ORGS	Proceeds From Increase In Cash From Business Combinations ProceedsFromIncreaseInCashFromBusinessCombinations		usd
CY2022	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity		usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2021	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders		usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2021	ORGS	Recognition Of Finance Lease Liability And Rightofuse Assets RecognitionOfFinanceLeaseLiabilityAndRightofuseAssets		usd
CY2021	ORGS	Rightofuse Assets Obtained In Exchange For New Operation Lease Liabilities RightofuseAssetsObtainedInExchangeForNewOperationLeaseLiabilities		usd
CY2021	ORGS	Loan Conversion For Redeemable Noncontrolling Interest LoanConversionForRedeemableNoncontrollingInterest		usd
CY2021	ORGS	Issuance Of Common Stocks In Connection With Acquisition IssuanceOfCommonStocksInConnectionWithAcquisition		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2022	ORGS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability		usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour		usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive		usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive		usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		usd
CY2021	ORGS	Equity Method Investments To Acquire Business Combination EquityMethodInvestmentsToAcquireBusinessCombination		usd
CY2021Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments		usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2021	ORGS	Accounts Receivable Acquisition Of Tlabs AccountsReceivableAcquisitionOfTlabs		usd
CY2021	ORGS	Contract With Customer Liability Addition ContractWithCustomerLiabilityAddition		usd
CY2022Q4	ORGS	Due From Related Parties Noncurrent1 DueFromRelatedPartiesNoncurrent1		usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-38416
CY2022	dei	Entity Registrant Name EntityRegistrantName	ORGENESIS INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0583166
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	20271 Goldenrod Lane
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Germantown
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20876
CY2022	dei	City Area Code CityAreaCode	(480)
CY2022	dei	Local Phone Number LocalPhoneNumber	659-6404
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2022	dei	Trading Symbol TradingSymbol	ORGS
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	54809919	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27493123	shares
CY2022	dei	Auditor Firm AuditorFirmId	1309
CY2022	dei	Auditor Name AuditorName	Kesselman & Kesselman
CY2022	dei	Auditor Location AuditorLocation	Tel Aviv, Israel
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5311000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5473000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1058000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	501000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36183000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15245000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	958000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1188000	usd
CY2022Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	2688000	usd
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	3064000	usd
CY2021Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	169000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	120000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	118000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	46318000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	25758000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	331000	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	363000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	135000	usd
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	584000	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	821000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22834000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10271000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9694000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11821000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2304000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1015000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	8187000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	8403000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	103000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1022000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	805000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	44610000	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	34083000	usd
CY2022Q4	us-gaap	Assets Assets	90928000	usd
CY2021Q4	us-gaap	Assets Assets	59841000	usd
CY2021Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	1972000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4429000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5238000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2578000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	485000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	289000	usd
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	54000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1860000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1907000	usd
CY2022Q4	ORGS	Advance Payments On Account Of Grant AdvancePaymentsOnAccountOfGrant	1578000	usd
CY2021Q4	ORGS	Advance Payments On Account Of Grant AdvancePaymentsOnAccountOfGrant	1238000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	70000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	59000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	60000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	18000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	542000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	481000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4504000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5885000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15910000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15365000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1728000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	561000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	13343000	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	4854000	usd
CY2022Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	163000	usd
CY2021Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	101000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	95000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	41000	usd
CY2022Q4	ORGS	Advance Payments On Account Of Grant Non Current AdvancePaymentsOnAccountOfGrantNonCurrent	144000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	271000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	288000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	15744000	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5845000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	31654000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	21210000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	30203000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	145833334	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	145833334	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25832322	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24567366	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25545755	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24280799	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	150355000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	145916000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-270000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	207000	usd
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	286567	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	286567	shares
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1266000	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1266000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-121261000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-106372000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	27561000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	38488000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	1510000	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	143000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29071000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	38631000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	90928000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	59841000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34741000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	31646000	usd
CY2022	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	1284000	usd
CY2021	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	3856000	usd
CY2022	us-gaap	Revenues Revenues	36025000	usd
CY2021	us-gaap	Revenues Revenues	35502000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	27066000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	36644000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	911000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	948000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15589000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14710000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1061000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-8602000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-16800000	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	173000	usd
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2278000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-52000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1865000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1971000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1292000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1508000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-272000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11960000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17951000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	209000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	108000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-12169000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-18059000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2720000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-6000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-14889000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-18053000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.74
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25096284	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24273658	shares
CY2022	us-gaap	Profit Loss ProfitLoss	-12169000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-18059000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-477000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-541000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest	-12646000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest	-18600000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest	-2720000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest	6000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15366000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18594000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	52728000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1349000	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	396000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	64000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	1848000	usd
CY2021	ORGS	Stock Issued During Period Value Issuance Of Shares Due To Exercise Of Warrants StockIssuedDuringPeriodValueIssuanceOfSharesDueToExerciseOfWarrants	1862000	usd
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1016000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-18600000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	38631000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	38631000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	916000	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	66000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	950000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	226000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2175000	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	100000	usd
CY2022	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	1353000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-12646000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29071000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-12169000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-18059000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	982000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1745000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	170000	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-25000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1508000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-272000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1978000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1864000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1061000	usd
CY2022	ORGS	Increase Decrease In Effect Of Exchange Differences On Intercompany Balances IncreaseDecreaseInEffectOfExchangeDifferencesOnIntercompanyBalances	502000	usd
CY2021	ORGS	Increase Decrease In Effect Of Exchange Differences On Intercompany Balances IncreaseDecreaseInEffectOfExchangeDifferencesOnIntercompanyBalances	341000	usd
CY2022	ORGS	Net Changes In Operating Leases NetChangesInOperatingLeases	61000	usd
CY2021	ORGS	Net Changes In Operating Leases NetChangesInOperatingLeases	4000	usd
CY2022	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	1372000	usd
CY2021	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	482000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-52000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1865000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	21051000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12178000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-55000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-26000	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	18000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-391000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	173000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1321000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3755000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1570000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-248000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-216000	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	487000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	10000	usd
CY2022	ORGS	Increase Decrease In Advance Payment On Account Of Grant IncreaseDecreaseInAdvancePaymentOnAccountOfGrant	722000	usd
CY2021	ORGS	Increase Decrease In Advance Payment On Account Of Grant IncreaseDecreaseInAdvancePaymentOnAccountOfGrant	433000	usd
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	103000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-24924000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26866000	usd
CY2021	ORGS	Payments For Investment In Convertible Loan To Related Party PaymentsForInvestmentInConvertibleLoanToRelatedParty	3000000	usd
CY2022	ORGS	Proceeds From Repayment Of Convertible Loan To Related Party Partners ProceedsFromRepaymentOfConvertibleLoanToRelatedPartyPartners	538000	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	4131000	usd
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	430000	usd
CY2021	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	818000	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	782000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	246000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12416000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7866000	usd
CY2021	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	242000	usd
CY2022	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	702000	usd
CY2022	ORGS	Proceeds From Increase In Cash From Business Combinations ProceedsFromIncreaseInCashFromBusinessCombinations	160000	usd
CY2022	ORGS	Repayment Of Investment In Longterm Deposits RepaymentOfInvestmentInLongtermDeposits	14000	usd
CY2021	ORGS	Repayment Of Investment In Longterm Deposits RepaymentOfInvestmentInLongtermDeposits	28000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14133000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12384000	usd
CY2021	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	1016000	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2181000	usd
CY2021	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1926000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	19150000	usd
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	20000000	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	2300000	usd
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1000000	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	46000	usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	16000	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1396000	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	803000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	39578000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-106000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	521000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-39356000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-126000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-238000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5974000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	45568000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6369000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5974000	usd
CY2022	ORGS	Recognition Of Finance Lease Liability And Rightofuse Assets RecognitionOfFinanceLeaseLiabilityAndRightofuseAssets	136000	usd
CY2022	ORGS	Rightofuse Assets Obtained In Exchange For New Operation Lease Liabilities RightofuseAssetsObtainedInExchangeForNewOperationLeaseLiabilities	432000	usd
CY2022	ORGS	Increase Decrease In Accounts Payable Related To Purchase Of Property Plant And Equipment IncreaseDecreaseInAccountsPayableRelatedToPurchaseOfPropertyPlantAndEquipment	-383000	usd
CY2021	ORGS	Increase Decrease In Accounts Payable Related To Purchase Of Property Plant And Equipment IncreaseDecreaseInAccountsPayableRelatedToPurchaseOfPropertyPlantAndEquipment	331000	usd
CY2022	ORGS	Loan Conversion For Redeemable Noncontrolling Interest LoanConversionForRedeemableNoncontrollingInterest	10203000	usd
CY2022	ORGS	Issuance Of Common Stocks In Connection With Acquisition IssuanceOfCommonStocksInConnectionWithAcquisition	100000	usd
CY2022	ORGS	Extinguishment In Connection With Convertible Loan Restructuring ExtinguishmentInConnectionWithConvertibleLoanRestructuring	226000	usd
CY2021	ORGS	Extinguishment In Connection With Convertible Loan Restructuring ExtinguishmentInConnectionWithConvertibleLoanRestructuring	1848000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	458000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	443000	usd
CY2022Q4	us-gaap	Grants Receivable GrantsReceivable	18000	eur
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-121000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-24900000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zZLnaQNq68Zc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>a. <span id="xdx_865_zdKoKRpuj0H7">Use of Estimates in the Preparation of Financial Statements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, judgments and methodologies. The Company bases its estimates on historical experience and on various other assumptions that it believes are reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity, the amount of revenues and expenses and determining whether an acquisition is a business combination or a purchase of asset. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The full extent to which the COVID-19 pandemic may directly or indirectly impact the Company’s business, results of operations and financial condition will depend on future developments that are uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain it or treat COVID-19, as well as the economic impact on local, regional, national and international customers and markets. The Company examined the impact of COVID-19 on the Company’s financial statements, and although there is currently no major impact, there may be changes to those estimates in future periods. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2022	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	When determining lease classification, the Company’s approach in assessing two of the mentioned criteria is: (i) generally 75% or more of the remaining economic life of the underlying asset is a major part of the remaining economic life of that underlying asset; and (ii) generally 90% or more of the fair value of the underlying asset comprises substantially all of the fair value of the underlying asset
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	greater than 50% likely of being realized upon ultimate settlement
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zOGggcpECXt5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>r. <span id="xdx_860_zsyzt0oWwkwg">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of principally cash and cash equivalents, <span style="background-color: white">bank deposits</span> and certain receivables. The Company held these instruments with highly rated financial institutions and the Company has not experienced any significant credit losses in these accounts and does not believe the Company is exposed to any significant credit risk on these instruments apart of accounts receivable. The Company performs ongoing credit evaluations of its customers for the purpose of determining the appropriate allowance for doubtful accounts. As of December 31, 2022, <span style="background-color: white">the Company does not have credit losses with respect to these accounts and does not believe it is exposed to significant credit risk on these instruments.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bad debt allowance is created when objective evidence exists of inability to collect all sums owed it under the original terms of the debit balances. Material customer difficulties, the probability of their going bankrupt or undergoing economic reorganization and insolvency, material delays in payments and other objective considerations by management that indicate expected risk of payment are all considered indicative of reduced debtor balance value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3042521	shares
CY2021Q4	ORGS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	6.09
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	7070241	shares
CY2020Q4	ORGS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	6.20
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	2978575	shares
CY2022	ORGS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice	3.16
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	926413	shares
CY2021	ORGS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice	6.24
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	319811	shares
CY2021	ORGS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice	6.19
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	639636	shares
CY2022	ORGS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirationsWeightedAverageExercisePrice	6.58
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	4634323	shares
CY2021	ORGS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirationsWeightedAverageExercisePrice	6.29
CY2022Q4	ORGS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding And Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumber	5381460	shares
CY2022Q4	ORGS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding And Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableWeightedAverageExercisePrice	4.41
CY2021Q4	ORGS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding And Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumber	3042521	shares
CY2021Q4	ORGS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding And Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableWeightedAverageExercisePrice	6.09
CY2021Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	231258	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased	4.34
CY2021Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	1004025000	usd
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25000000.0	usd
CY2018	ORGS	Commission Rate CommissionRate	0.030	pure
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	26786000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13211000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3952000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2940000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22834000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10271000	usd
CY2022	us-gaap	Depreciation Depreciation	1067000	usd
CY2021	us-gaap	Depreciation Depreciation	916000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	12805000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14753000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12805000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	103000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22834000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10271000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22834000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10271000	usd
CY2020Q4	us-gaap	Goodwill Goodwill	8745000	usd
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-342000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	8403000	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-216000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	8187000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	12420000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	13696000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2726000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1875000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9694000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11821000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	911000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	948000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	840000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3362000	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	2300000	usd
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1000000	usd
CY2022	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	0.10	pure
CY2022	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	0.10	pure
CY2022	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	1865000	usd
CY2022	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	4400000	usd
CY2018Q1	us-gaap	Convertible Debt ConvertibleDebt	383000	usd
CY2018Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.52
CY2018Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	107985	shares
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2304000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1015000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	222000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	91000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	68000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	33000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	154000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	58000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	542000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	481000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	60000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	18000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1728000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	561000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	95000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	41000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y8M12D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y4M24D
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y2M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.080	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.069	pure
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.064	pure
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.020	pure
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	546000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	514000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	43000	usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	20000	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	7000	usd
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1000	usd
CY2022	ORGS	Finance Lease Cost FinanceLeaseCost	50000	usd
CY2021	ORGS	Finance Lease Cost FinanceLeaseCost	21000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	559000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	526000	usd
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	43000	usd
CY2021	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	20000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	432000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	136000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	681000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	69000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	539000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	69000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	367000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	30000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	213000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	213000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	960000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2973000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	168000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	703000	usd
CY2022Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	13000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2270000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	155000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	542000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	60000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1728000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	95000	usd
CY2022	ORGS	Schedule Of Rightofuse Assets By Geographical Location ScheduleOfRightofuseAssetsByGeographicalLocation	<p id="xdx_893_ecustom--ScheduleOfRightofuseAssetsByGeographicalLocation_zL3xLaZFc6k6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease right-of-use assets by geographical location were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zCDbtGjoO7Xc" style="display: none">SCHEDULE OF RIGHT-OF-USE ASSETS BY GEOGRAPHICAL LOCATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in thousands)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Greece</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__country--GR_zLJyVgRafFs8" style="width: 16%; text-align: right" title="Operating lease right-of-use assets">1,368</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_c20211231__srt--StatementGeographicalAxis__country--GR_zbtX8jhYiwGg" style="width: 16%; text-align: right" title="Operating lease right-of-use assets"><span style="-sec-ix-hidden: xdx2ixbrl1759">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Korea</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__country--KR_zA1x3uNa476b" style="text-align: right" title="Operating lease right-of-use assets">218</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_c20211231__srt--StatementGeographicalAxis__country--KR_zVsl4rxDKa96" style="text-align: right" title="Operating lease right-of-use assets">432</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Israel</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__country--IL_zF9IPtaNhaQl" style="text-align: right" title="Operating lease right-of-use assets">580</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_c20211231__srt--StatementGeographicalAxis__country--IL_zKImRhGPOof5" style="text-align: right" title="Operating lease right-of-use assets">365</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">U.S.</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__country--US_z2r1O87s4DPk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Operating lease right-of-use assets">138</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_c20211231__srt--StatementGeographicalAxis__country--US_z9XswxUlSUYb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Operating lease right-of-use assets">218</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_c20221231_zTCREaDlUX" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right-of-use assets">2,304</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_c20211231_zcR1959lau15" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right-of-use assets">1,015</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2304000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1015000	usd
CY2022	ORGS	Repayments Of Grant Percentage Of Gross Sales RepaymentsOfGrantPercentageOfGrossSales	0.05	pure
CY2022	ORGS	Royalty Of Net Sales Percentage RoyaltyOfNetSalesPercentage	0.035	pure
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	120000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	609000	usd
CY2021Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	5000000	usd
CY2021	us-gaap	Payments For Rent PaymentsForRent	260000	usd
CY2021Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P10Y
CY2022	ORGS	Royalties Rate RoyaltiesRate	0.15	pure
CY2021Q4	us-gaap	Loans Payable LoansPayable	2000000	eur
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	2706000	usd
CY2022Q4	us-gaap	Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue	1000	usd
CY2022Q4	us-gaap	Loans Payable LoansPayable	2000000	eur
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12805000	usd
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11932000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-1948000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-873000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14753000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12805000	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	584000	usd
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	175000	usd
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	260000	usd
CY2022	ORGS	Payment To Acquire Loan To Granted Associations PaymentToAcquireLoanToGrantedAssociations	4131000	usd
CY2021	ORGS	Payment To Acquire Loan To Granted Associations PaymentToAcquireLoanToGrantedAssociations	441000	usd
CY2022	ORGS	Equity Method Investments To Acquire Business Combination EquityMethodInvestmentsToAcquireBusinessCombination	-3156000	usd
CY2022	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	161000	usd
CY2021	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	2000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1508000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-272000	usd
CY2022	ORGS	Equity Method Investment Exchange Rate Difference EquityMethodInvestmentExchangeRateDifference	-77000	usd
CY2021	ORGS	Equity Method Investment Exchange Rate Difference EquityMethodInvestmentExchangeRateDifference	-22000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	135000	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	584000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-14889000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-18053000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25096284	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24273658	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.74
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	510017	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.012
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	64000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	13750	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.63
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	22000000	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	29000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10387000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11451000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1893000	usd
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1273000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1616000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2631000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	191000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	197000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	55000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	206000	usd
CY2022Q4	ORGS	Deferred Tax Assets Leases Asset DeferredTaxAssetsLeasesAsset	191000	usd
CY2021Q4	ORGS	Deferred Tax Assets Leases Asset DeferredTaxAssetsLeasesAsset	186000	usd
CY2022Q4	ORGS	Deferred Tax Liabilities Lease Liability DeferredTaxLiabilitiesLeaseLiability	132000	usd
CY2021Q4	ORGS	Deferred Tax Liabilities Lease Liability DeferredTaxLiabilitiesLeaseLiability	134000	usd
CY2022Q4	ORGS	Deferred Tax Assets Loans DeferredTaxAssetsLoans	50000	usd
CY2021Q4	ORGS	Deferred Tax Assets Loans DeferredTaxAssetsLoans	26000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	2582000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	2252000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	2738000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	385000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	119000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	14856000	usd
CY2022	us-gaap	Revenues Revenues	36025000	usd
CY2021	us-gaap	Revenues Revenues	35502000	usd
CY2022	ORGS	Schedule Of Breakdown Of Revenues Per Customer ScheduleOfBreakdownOfRevenuesPerCustomer	<p id="xdx_898_ecustom--ScheduleOfBreakdownOfRevenuesPerCustomer_zrycXSSyn0E8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A breakdown of the revenues per customer what constituted at least 10% of revenues is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span id="xdx_8BE_zqvEwKxkb5Pg" style="display: none">SCHEDULE OF BREAKDOWN OF REVENUES PER CUSTOMER</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">(in thousands)</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Revenue earned:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: justify">Customer A (Greece)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerAMember_zi4hGAoTOsll" style="width: 16%; text-align: right" title="Customer A (Greece)">8,936</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerAMember_zLpwBd3t0mA9" style="width: 16%; text-align: right" title="Customer A (Greece)">4,693</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Customer B (United States)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerBMember_zJ8UjNG6zp5e" style="text-align: right" title="Customer B (China)">8,316</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerBMember_zqelX8Erqj29" style="text-align: right" title="Customer B (China)">6,491</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer C (United Arab Emirates)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerCMember_zAAN55Dxcj35" style="text-align: right" title="Revenue earned">5,271</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerCMember_zyr4vOWjv8a7" style="text-align: right" title="Revenue earned">6,969</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Customer D (Korea)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Revenue earned"><p id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerDMember_zFzKOfJqfMOe" style="margin: 0" title="Revenue earned">3,873</p></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Revenue earned"><p id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerDMember_zq7LEOo0hwy7" style="margin: 0" title="Revenue earned">7,703</p></td><td style="text-align: left"> </td></tr> </table>
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15245000	usd
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3085000	usd
CY2022	ORGS	Accounts Receivable Acquisition Of Tlabs AccountsReceivableAcquisitionOfTlabs	-1339000	usd
CY2022	ORGS	Accounts Receivable Additions AccountsReceivableAdditions	35103000	usd
CY2021	ORGS	Accounts Receivable Additions AccountsReceivableAdditions	34570000	usd
CY2022	ORGS	Accounts Receivable Collections AccountsReceivableCollections	-12728000	usd
CY2021	ORGS	Accounts Receivable Collections AccountsReceivableCollections	-22333000	usd
CY2022	ORGS	Exchange Rate Differences Of Accounts Receivable ExchangeRateDifferencesOfAccountsReceivable	-98000	usd
CY2021	ORGS	Exchange Rate Differences Of Accounts Receivable ExchangeRateDifferencesOfAccountsReceivable	-77000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36183000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15245000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	59000	usd
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	59000	usd
CY2022	ORGS	Contract With Customer Liability Addition ContractWithCustomerLiabilityAddition	11000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	70000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	59000	usd
CY2022	ORGS	Interest Expense On Convertible Loans InterestExpenseOnConvertibleLoans	1824000	usd
CY2021	ORGS	Interest Expense On Convertible Loans InterestExpenseOnConvertibleLoans	943000	usd
CY2022	ORGS	Foreign Currency Transactions Gain Loss Realized ForeignCurrencyTransactionsGainLossRealized	145000	usd
CY2021	ORGS	Foreign Currency Transactions Gain Loss Realized ForeignCurrencyTransactionsGainLossRealized	574000	usd
CY2022	us-gaap	Other Income OtherIncome	-2000	usd
CY2021	us-gaap	Other Income OtherIncome	225000	usd
CY2022	ORGS	Total Financial Expenses TotalFinancialExpenses	1971000	usd
CY2021	ORGS	Total Financial Expenses TotalFinancialExpenses	1292000	usd
CY2021Q4	ORGS	Due From Related Parties Noncurrent1 DueFromRelatedPartiesNoncurrent1	3064000	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1972000	usd
CY2022	us-gaap	Loss Contingency Actions Taken By Plaintiff LossContingencyActionsTakenByPlaintiff	the plaintiffs are seeking that the Court issue a declaratory remedy whereby the defendants are required to pay royalties to the plaintiffs at the rate of 7% of the sales and 24% of any and all revenues in consideration for sublicenses related to any product, service or process that contains know-how and technology of Sheba and any and all know-how and technology either developed or supervised by Prof. Ferber in the field of cell therapy, including in the category of the point-of-care platform and any and all services and products in relation to the defendants’ CDMO activity.

Files In Submission

Name	View Source	Status
0001493152-23-008574-index-headers.html	Edgar Link	pending
0001493152-23-008574-index.html	Edgar Link	pending
0001493152-23-008574.txt	Edgar Link	pending
0001493152-23-008574-xbrl.zip	Edgar Link	pending
orgs-20221231_cal.xml	Edgar Link	unprocessable
orgs-20221231_def.xml	Edgar Link	unprocessable
ex21-1.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
form10-k_002.jpg	Edgar Link	pending
form10-k_003.jpg	Edgar Link	pending
form10-k_004.jpg	Edgar Link	pending
form10-k_005.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
orgs-20221231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
orgs-20221231_lab.xml	Edgar Link	unprocessable
orgs-20221231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORGS
Orgenesis Inc. Stock $orgs

2023 Q1 Form 10-K Financial Statement

#000149315223008574 Filed on March 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGS Orgenesis Inc. Stock $orgs

2023 Q1 Form 10-K Financial Statement

#000149315223008574 Filed on March 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGS
Orgenesis Inc. Stock $orgs